| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |